MX2010003972A - Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium. - Google Patents
Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium.Info
- Publication number
- MX2010003972A MX2010003972A MX2010003972A MX2010003972A MX2010003972A MX 2010003972 A MX2010003972 A MX 2010003972A MX 2010003972 A MX2010003972 A MX 2010003972A MX 2010003972 A MX2010003972 A MX 2010003972A MX 2010003972 A MX2010003972 A MX 2010003972A
- Authority
- MX
- Mexico
- Prior art keywords
- response against
- compositions
- map
- immune response
- eliciting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se proveen composiciones y métodos para estimular una respuesta inmune contra paratuberculosis sub-especie Mycobacterium avium (MAP). Las composiciones incluyen un polipéptido recombinante que contiene de su término N a término C un fragmento C-terminal de Map3527 de proteína de MAP, una secuencia de aminoácidos de proteína Map1519, seguida por una porción N-terminal de Map3527. El método comprende administrar la composición a un animal en una cantidad efectiva para estimular respuesta inmunológica contra bacterias MAP. El método es de beneficio para cualquier animal susceptible a infección de MAP, pero es particularmente benéfico para rumiantes.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97982207P | 2007-10-13 | 2007-10-13 | |
| US9455208P | 2008-09-05 | 2008-09-05 | |
| PCT/US2008/079425 WO2009049097A1 (en) | 2007-10-13 | 2008-10-09 | Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003972A true MX2010003972A (es) | 2010-08-09 |
Family
ID=40534814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003972A MX2010003972A (es) | 2007-10-13 | 2008-10-09 | Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7732580B2 (es) |
| EP (1) | EP2200641B1 (es) |
| JP (1) | JP2011500587A (es) |
| KR (1) | KR20100098602A (es) |
| CN (1) | CN101883582B (es) |
| AU (1) | AU2008310767A1 (es) |
| BR (1) | BRPI0817892A2 (es) |
| CA (1) | CA2704178A1 (es) |
| CO (1) | CO6270338A2 (es) |
| ES (1) | ES2390996T3 (es) |
| IN (1) | IN2010DN02553A (es) |
| MX (1) | MX2010003972A (es) |
| NZ (1) | NZ584659A (es) |
| PL (1) | PL2200641T3 (es) |
| PT (1) | PT2200641E (es) |
| RU (1) | RU2489165C2 (es) |
| WO (1) | WO2009049097A1 (es) |
| ZA (1) | ZA201002553B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9808517B2 (en) | 2012-04-06 | 2017-11-07 | Cornell University | Subunit vaccine delivery platform for robust humoral and cellular immune responses |
| US9175049B2 (en) | 2012-10-24 | 2015-11-03 | The United States Of America, As Represented By The Secretary Of Agriculture | Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322858A (en) * | 1992-02-14 | 1994-06-21 | Jacobus Pharmaceutical Co. Inc. | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
| AU753995B2 (en) * | 1998-04-07 | 2002-10-31 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| ATE526994T1 (de) * | 2000-06-20 | 2011-10-15 | Corixa Corp | Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten |
| US7074559B2 (en) * | 2002-03-06 | 2006-07-11 | Refents of the University of Minnesota | Mycobacterial diagnostics |
| CN101155596B (zh) | 2005-02-16 | 2012-05-30 | 康奈尔研究基金会股份有限公司 | 引发抗禽分枝杆菌副结核亚种的免疫应答的组合物 |
| US8758773B2 (en) | 2005-12-09 | 2014-06-24 | Wisconsin Alumni Research Foundation | Vaccine candidates against Johne's disease |
-
2008
- 2008-10-09 US US12/248,764 patent/US7732580B2/en not_active Expired - Fee Related
- 2008-10-09 PL PL08837410T patent/PL2200641T3/pl unknown
- 2008-10-09 ES ES08837410T patent/ES2390996T3/es active Active
- 2008-10-09 WO PCT/US2008/079425 patent/WO2009049097A1/en active Application Filing
- 2008-10-09 EP EP08837410A patent/EP2200641B1/en active Active
- 2008-10-09 RU RU2010119046/15A patent/RU2489165C2/ru not_active IP Right Cessation
- 2008-10-09 CN CN200880119048.7A patent/CN101883582B/zh not_active Expired - Fee Related
- 2008-10-09 PT PT08837410T patent/PT2200641E/pt unknown
- 2008-10-09 JP JP2010529059A patent/JP2011500587A/ja not_active Ceased
- 2008-10-09 CA CA2704178A patent/CA2704178A1/en not_active Abandoned
- 2008-10-09 KR KR1020107010437A patent/KR20100098602A/ko not_active Application Discontinuation
- 2008-10-09 MX MX2010003972A patent/MX2010003972A/es not_active Application Discontinuation
- 2008-10-09 BR BRPI0817892 patent/BRPI0817892A2/pt not_active IP Right Cessation
- 2008-10-09 NZ NZ584659A patent/NZ584659A/en not_active IP Right Cessation
- 2008-10-09 AU AU2008310767A patent/AU2008310767A1/en not_active Abandoned
-
2010
- 2010-04-12 ZA ZA2010/02553A patent/ZA201002553B/en unknown
- 2010-04-13 IN IN2553DEN2010 patent/IN2010DN02553A/en unknown
- 2010-05-13 CO CO10057537A patent/CO6270338A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2200641A4 (en) | 2010-09-29 |
| US20090099083A1 (en) | 2009-04-16 |
| CA2704178A1 (en) | 2009-04-16 |
| BRPI0817892A2 (pt) | 2015-05-05 |
| PT2200641E (pt) | 2012-10-11 |
| ES2390996T3 (es) | 2012-11-20 |
| EP2200641A1 (en) | 2010-06-30 |
| JP2011500587A (ja) | 2011-01-06 |
| PL2200641T3 (pl) | 2012-12-31 |
| KR20100098602A (ko) | 2010-09-08 |
| AU2008310767A1 (en) | 2009-04-16 |
| EP2200641B1 (en) | 2012-07-04 |
| US7732580B2 (en) | 2010-06-08 |
| CN101883582A (zh) | 2010-11-10 |
| WO2009049097A1 (en) | 2009-04-16 |
| NZ584659A (en) | 2011-09-30 |
| RU2489165C2 (ru) | 2013-08-10 |
| IN2010DN02553A (es) | 2015-07-24 |
| RU2010119046A (ru) | 2011-11-20 |
| CN101883582B (zh) | 2014-03-19 |
| ZA201002553B (en) | 2010-12-29 |
| CO6270338A2 (es) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ745324A (en) | Vaccines and vaccine components for inhibition of microbial cells | |
| BRPI0721003B8 (pt) | composições e uso | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| UA107329C2 (uk) | Туберкульозний білок rv2386c, композиція, що його містить, та застосування | |
| TW201129379A (en) | Anti-Orai1 antigen binding proteins and uses thereof | |
| WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
| MX348071B (es) | Variantes de fc. | |
| EP2532366A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER | |
| PE20121360A1 (es) | Anticuerpos neutralizadores contra el receptor de prolactina | |
| UA107180C2 (uk) | Туберкульозний білок rv1753c, композиція, що його містить, та застосування | |
| JP2017522319A5 (es) | ||
| NZ601591A (en) | Methods for treating pancreatic cancer | |
| MX2011008759A (es) | Medios y metodos para fabricar neurotoxina altamente pura. | |
| NZ591612A (en) | Prevention, treatment and diagnosis of p.gingivalis infection with peptides | |
| NZ609216A (en) | Anticancer fusion protein | |
| NZ766003A (en) | Factor h binding protein variants and methods of use thereof | |
| MX2014004132A (es) | Señuelos humanos notch1. | |
| MA32770B1 (fr) | Anticorps anti-peptides igf-1/e humain modifie | |
| NZ596501A (en) | Casb7439 constructs | |
| NZ601980A (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| BR112013025975A2 (pt) | proteína de fusão anticancerígena | |
| MX2010003972A (es) | Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium. | |
| NZ591133A (en) | Novel melanoma antigen peptide and uses thereof | |
| MX2022008298A (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. | |
| NZ700199A (en) | Epsilon toxin epitopes from clostridium perfringens with reduced toxicity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |